Morgan Stanley initiated coverage on Ametek with a new price target
$AME
Industrial Machinery/Components
Industrials
Morgan Stanley initiated coverage of Ametek with a rating of Equal-Weight and set a new price target of $170.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/27/2026 | Outperform → Perform | Oppenheimer | |
| 1/21/2026 | $271.00 | Buy | Deutsche Bank |
| 1/5/2026 | $235.00 | Hold → Buy | Melius |
| 12/23/2025 | Hold → Buy | TD Cowen | |
| 9/10/2025 | $200.00 | Equal Weight | Barclays |
| 9/2/2025 | $180.00 | Sell → Hold | TD Cowen |
| 7/14/2025 | $192.00 | Buy → Hold | Melius |
| 4/14/2025 | $170.00 | Equal-Weight | Morgan Stanley |
8-K - AMETEK INC/ (0001037868) (Filer)
8-K - AMETEK INC/ (0001037868) (Filer)
10-Q - AMETEK INC/ (0001037868) (Filer)
Oppenheimer downgraded Ametek from Outperform to Perform
Deutsche Bank resumed coverage of Ametek with a rating of Buy and set a new price target of $271.00
Melius upgraded Ametek from Hold to Buy and set a new price target of $235.00
TORONTO and PARK CITY, Utah, Feb. 3, 2026 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the sale of LKC Technologies to AMETEK, Inc. (NYSE:AME). As leaders in the world of visual electrophysiology, LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, is dedicated to preserving sight by expanding access to objective functional retinal assessments. For over 35 years, LKC has pioneered innovations in diagnostic technology, transforming complex visual electrophysiology into intuitive, accessibl
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the acquisition of LKC Technologies, a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC Technologies develops portable devices that help doctors test and monitor eye health. These innovative tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss. "We are excited to welcome LKC Technologies to AMETEK," said David A. Zapico, AMETEK Chairman and Chief Executive Officer. "LKC Technologies is an excellent strategic fit with our Ultra Precision Technologies Reichert busin
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced its financial results for the fourth quarter ended December 31, 2025. AMETEK's fourth quarter 2025 sales were a record $2.0 billion, a 13% increase over the fourth quarter of 2024. On a GAAP basis, fourth quarter earnings were a record $1.73 per diluted share. Adjusted earnings in the quarter were a record $2.01 per diluted share, up 7% from the fourth quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.22 per diluted share and excludes acquisition-related pre-tax costs of $17.6 million, or $0.06 per diluted share, for the Faro Technologies acquis
3 - AMETEK INC/ (0001037868) (Issuer)
4 - AMETEK INC/ (0001037868) (Issuer)
4 - AMETEK INC/ (0001037868) (Issuer)
Tom Montgomery to Retire Following 42 Years of Service BERWYN, Pa., Nov. 7, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of Robert J. Amodei as Senior Vice President, Controller effective January 1, 2026. Mr. Amodei currently serves as Vice President, Assistant Controller. He will replace Thomas M. Montgomery who has announced his retirement after 42 years of distinguished service with AMETEK. Mr. Montgomery will remain with the company as a Senior Advisor through 2026. AMETEK also announced the appointment of Scott M. DelOrefice as Vice President, Group Controller, Electromechanical Group effective January 1, 2026. Mr. DelOrefice currently serves as Divisiona
BERWYN, Pa., and LAKE MARY, Fla., May 6, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) and FARO Technologies, Inc. (NASDAQ:FARO) today announced that they have entered into a definitive agreement under which AMETEK will acquire all outstanding shares of FARO Technologies common stock for $44 per share in cash, which represents an approximate 40% premium to FARO's closing price on May 5, 2025. The transaction values FARO at an enterprise value of approximately $920 million. The boards of directors of both companies have unanimously approved the transaction. Founded in 1981 and headquartered in Lake Mary, Florida, FARO Technologies is a leading provider of 3D measurement and imaging solutions,
BERWYN, Pa., March 3, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of Jennifer G. Hellberg as Vice President, Human Resources. Ms. Hellberg most recently served as Divisional Vice President and Business Unit Manager for the Zygo and Navitar businesses within AMETEK's Ultra Precision Technologies Division. "I am pleased to announce Jennifer's promotion to Vice President, Human Resources," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Jennifer has demonstrated outstanding leadership and strategic vision during her time at AMETEK. I am confident she will continue to enhance our global human resources organization and support AMETEK's l
TORONTO and PARK CITY, Utah, Feb. 3, 2026 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the sale of LKC Technologies to AMETEK, Inc. (NYSE:AME). As leaders in the world of visual electrophysiology, LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, is dedicated to preserving sight by expanding access to objective functional retinal assessments. For over 35 years, LKC has pioneered innovations in diagnostic technology, transforming complex visual electrophysiology into intuitive, accessibl
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the acquisition of LKC Technologies, a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC Technologies develops portable devices that help doctors test and monitor eye health. These innovative tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss. "We are excited to welcome LKC Technologies to AMETEK," said David A. Zapico, AMETEK Chairman and Chief Executive Officer. "LKC Technologies is an excellent strategic fit with our Ultra Precision Technologies Reichert busin
BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced its financial results for the fourth quarter ended December 31, 2025. AMETEK's fourth quarter 2025 sales were a record $2.0 billion, a 13% increase over the fourth quarter of 2024. On a GAAP basis, fourth quarter earnings were a record $1.73 per diluted share. Adjusted earnings in the quarter were a record $2.01 per diluted share, up 7% from the fourth quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.22 per diluted share and excludes acquisition-related pre-tax costs of $17.6 million, or $0.06 per diluted share, for the Faro Technologies acquis
SC 13G/A - AMETEK INC/ (0001037868) (Subject)
SC 13G/A - AMETEK INC/ (0001037868) (Subject)
SC 13G/A - AMETEK INC/ (0001037868) (Subject)